Four years after India allowed 100% foreign direct investment (FDI) in the medical device industry through the “automatic route” requiring no government approval, inflows have crashed.
The Indian association representing multinational medical technology firms blames government price controls imposed on prices of stents and knee implants that were aimed at lowering costs for patients.